ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer

Abstract Activating mutations of fibroblast growth factor receptor 3 (FGFR3) are common in urothelial carcinoma of the bladder (UC). Silencing or inhibition of mutant FGFR3 in bladder cancer cell lines is associated with decreased malignant potential, confirming its important driver role in UC. Howe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Erica di Martino, Olivia Alder, Carolyn D. Hurst, Margaret A. Knowles
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7bb60571b5e24f2aa7be8f839790e504
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!